US2981641A - Tobacco products - Google Patents

Tobacco products Download PDF

Info

Publication number
US2981641A
US2981641A US3718A US371860A US2981641A US 2981641 A US2981641 A US 2981641A US 3718 A US3718 A US 3718A US 371860 A US371860 A US 371860A US 2981641 A US2981641 A US 2981641A
Authority
US
United States
Prior art keywords
tobacco
nicotine
nornicotine
salt
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US3718A
Inventor
Robert C O'neill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stauffer Chemical Co
Original Assignee
Stauffer Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stauffer Chemical Co filed Critical Stauffer Chemical Co
Priority to US3718A priority Critical patent/US2981641A/en
Application granted granted Critical
Publication of US2981641A publication Critical patent/US2981641A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/28Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/38Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only nitrogen as hetero atom

Description

TOBACCO PRODUCTS Robert C. ONeill, New York, N.Y., assignor to Stauifer Chemical Company, New York, N.Y., a corporation of Delaware No Drawing. Filed Jan. 21, 1960, Ser. No. 3,718
7 Claims. (Cl. 131-17) The present invention is concerned with treated tobacco products. In particular, it deals with tobacco in which there has been incorporated a compound which is an antagonist for nicotine and which has a particular chemical structure.
The compounds useful in the present invention as antagonists for nicotine are chemically related to nicotine itself,- but they differ from nicotine in that the methyl group present on the nitrogen atom in the -membered ring of nicotine has been replaced by a lower alkyl group containing from 2 to 8 carbon atoms. As examples of suitable alkyl groups there may be mentioned the ethyl group, the propyl group, the isopropyl group, the hexyl group, the isobutyl group, the octyl group and the allyl group.
The antagonist may be used in the form of a free base, but it is preferred to use it in the form of a salt of an acid. It is most preferred to use the antagonist as the salt of an organic acid, particularly an organic acid which naturally forms salts with nicotine in tobacco, e.g. citric acid and malic acid.
Many persons who smoke desire to break the smoking habit. The reasons for desiring to break the habit are many and varied, and may be based on advice from a physician or purely on economic considerations. In any case it has been the experience of numerous smokers, and particularly of very heavy smokers, that it is very difficult to give up the tobacco habit.
The compositions of the present invention are useful in assisting a smoker to break the tobacco habit. Tobaccos treated in accordance with the present invention, when burned in accordance with usual smoking practice, yield a smoke which contains vapors of the compound which is antagonistic to nicotine. The smoke provides the desired aroma and taste of smoke from conventional tobacco, but because of the antagonistic action of the additives, the physiological responses elicited by nicotine and related alkaloids naturally in tobacco are diminished. This diminished physiological response helps the smoker to stop smoking or to reduce the smoking habit.
In accordance with the present invention the nicotine antagonist, which is in all cases a tertiary amine, is incorporated in the tobacco, preferably in the form of a salt with an organic acid with naturally occurs with nicotine in tobacco, for example citric and malic acids. A solution of the salt is sprayed on the tobacco prior to the final processing steps in which it is made into the usual forms such as cigarettes, cigars and pipe tobacco. The amount of antagonist to be incorporated in the tobacco is preferably of the same order of magnitude as the amount of nicotine present in the tobacco. Information pnblished in the scientific literature indicates that the amount of nicotine present in tobacco varies from 0.5 to 8.0%. In the case of cigarette tobacco, the usual range is from 0.7 to 3.0%, with about 1.5% being an average value.
United ntates Patent The N-alkyl nornicotine compounds of the present invention are prepared by the reaction of nornicotine, which occurs naturally in tobacco, and the appropriate alkyl halide. The acid addition salts are prepared by simple reaction between the free base and an acid, for example, acetic acid, hydrochloric acid, sulfuric acid, phosphoric acid, citric acid and malic acid.
The following examples are given solely for the purposes of illustration and are not to be considered limitations of the invention, many variations of which will occur to those skilled in the art without departing from the spirit or scope thereof.
Example 1 Tobacco leaves are sprayed with an aqueous solution of the citrate salt of N-allyl nornicotine, so that after drying, the tobacco contains 3% of the added material. The spraying operation is conducted so that the additive is uniformly distributed throughout the tobacco mass. The tobacco is then processed in the normal fashion, and made into cigarettes, cigars or pipe tobacco as desired.
Smokers who substitute tobacco treated in accordance with the present invention for their normal conventional cigars, pipes or cigarettes experience the same desirable taste as with conventional tobacco, but also experience a decrease in the craving for tobacco. The subjects find that less will power is required in order to decrease or completely eliminate the smoking habit.
Example 2 The procedure of Example 1 may be repeated except that in place of the citrate salt, the malic acid salt is used. In like manner, when in place of N-allyl nornicotine, N-ethyl nornicotine, Nhexyl nornicotine or N-octyl nornicotine is used, either in the form of the free base or an acid addition salt, similar results are obtained. The concentration of the additive may be varied from 0.5 to 8.0%.
What is claimed is:
1. As a novel composition of matter, tobacco comprising from 0.5 to 8.0% of a compound selected from the group consisting of N-alkyl nornicotine compounds containing from 2 to 8 carbon atoms in the alkyl group, and acid addition salts thereof.
2. As a novel composition of matter, tobacco comprising from 0.5 to 8.0% of an N-alkyl nornicotine compound containing from 2 to 8 carbon atoms in the alkyl group, said compound being present in the form of a salt of an organic acid which naturally forms a salt with nicotine in tobacco.
3. As a novel composition of matter, tobacco comprising from 0.5 to 8.0% of N-allyl nornicotine in the form of a salt of an organic acid which naturally forms a salt with nicotine in tobacco.
4. As a novel composition of matter, tobacco comprising from 0.7 to 3.0% of an N-alkyl nornicotine compound containing from 2 to 8 carbon atoms in the alkyl group, said compound being present in the form of a salt of an organic acid which naturally forms a salt with nicotine in tobacco.
5. As a novel composition of matter, tobacco comprising from 0.7 to 3.0% of N-allyl nornicotine in the form of a salt of an organic acid which naturally'forms a salt with nicotine in tobacco.
6. As a novel composition of matter, tobacco comprising from 0.5 to 8.0% of N-allyl nornicotine citrate.
7. As a novel composition of matter, tobacco comprising from 0.7 to 3.0% of N-allyl nornicotine citrate.
No references cited.

Claims (1)

1. AS A NOVEL COMPOSITION OF MATTER, TOBACCO COMPRISING FROM 0.5 TO 8.0% OF A COMPOUND SELECTED FROM THE GROUP CONSISTING OF N-ALKYL NORNICOTINE COMPOUNDS CONTAINING FROM 2 TO 8 CARBON ATOMS IN THE ALKYL GROUP, AND ACID ADDITION SALTS THEREOF.
US3718A 1960-01-21 1960-01-21 Tobacco products Expired - Lifetime US2981641A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US3718A US2981641A (en) 1960-01-21 1960-01-21 Tobacco products

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3718A US2981641A (en) 1960-01-21 1960-01-21 Tobacco products

Publications (1)

Publication Number Publication Date
US2981641A true US2981641A (en) 1961-04-25

Family

ID=21707244

Family Applications (1)

Application Number Title Priority Date Filing Date
US3718A Expired - Lifetime US2981641A (en) 1960-01-21 1960-01-21 Tobacco products

Country Status (1)

Country Link
US (1) US2981641A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3071509A (en) * 1961-03-09 1963-01-01 Stauffer Chemical Co N-alkyl-nornicotine:nicotine antagonist
US4765348A (en) * 1986-12-12 1988-08-23 Brown & Williamson Tobacco Corporation Non-combustible simulated cigarette device
US5316759A (en) * 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
WO1996027303A1 (en) * 1995-03-06 1996-09-12 Lectec Corporation Nicotine-free smoking material
US5596007A (en) * 1992-05-18 1997-01-21 Pharmaco Behavioral Associates, Inc. Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine
US5612357A (en) * 1992-05-18 1997-03-18 Pharmaco Behavioral Associates, Inc. Use of cotinine to assist in the cessation of tobacco smoking
US20080233197A1 (en) * 2006-06-19 2008-09-25 Francis Joseph Matthews Pharmaceutical compositions
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US20100152221A1 (en) * 2007-12-17 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US20100266645A1 (en) * 2007-12-17 2010-10-21 Alfred Liang Pharmaceutical compositions
US20110014280A1 (en) * 2002-09-20 2011-01-20 Garth Boehm Sequestering subunit and related compositions and methods

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3071509A (en) * 1961-03-09 1963-01-01 Stauffer Chemical Co N-alkyl-nornicotine:nicotine antagonist
US5316759A (en) * 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
US5574052A (en) * 1986-03-17 1996-11-12 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
US5935975A (en) * 1986-03-17 1999-08-10 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
US4765348A (en) * 1986-12-12 1988-08-23 Brown & Williamson Tobacco Corporation Non-combustible simulated cigarette device
US5596007A (en) * 1992-05-18 1997-01-21 Pharmaco Behavioral Associates, Inc. Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine
US5612357A (en) * 1992-05-18 1997-03-18 Pharmaco Behavioral Associates, Inc. Use of cotinine to assist in the cessation of tobacco smoking
WO1996027303A1 (en) * 1995-03-06 1996-09-12 Lectec Corporation Nicotine-free smoking material
US5880164A (en) * 1995-03-06 1999-03-09 Lectec Corporation Nicotine-free smoking material
US20110027455A1 (en) * 2002-09-20 2011-02-03 Garth Boehm Sequestering subunit and related compositions and methods
US20110014280A1 (en) * 2002-09-20 2011-01-20 Garth Boehm Sequestering subunit and related compositions and methods
US8685443B2 (en) 2002-09-20 2014-04-01 Alpharma Pharmaceuticals Llc Sequestering subunit and related compositions and methods
US8685444B2 (en) 2002-09-20 2014-04-01 Alpharma Pharmaceuticals Llc Sequestering subunit and related compositions and methods
US8158156B2 (en) 2006-06-19 2012-04-17 Alpharma Pharmaceuticals, Llc Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
US20100143483A1 (en) * 2006-06-19 2010-06-10 Alpharma Pharmaceuticals, Llc. Pharmaceutical compositions
US20080233197A1 (en) * 2006-06-19 2008-09-25 Francis Joseph Matthews Pharmaceutical compositions
US20090162450A1 (en) * 2006-06-19 2009-06-25 Alpharma Pharmaceuticals, Llc. Pharmaceutical composition
US7682633B2 (en) 2006-06-19 2010-03-23 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US7682634B2 (en) 2006-06-19 2010-03-23 Alpharma Pharmaceuticals, Llc Pharmaceutical compositions
US8846104B2 (en) 2006-06-19 2014-09-30 Alpharma Pharmaceuticals Llc Pharmaceutical compositions for the deterrence and/or prevention of abuse
US8877247B2 (en) 2006-06-19 2014-11-04 Alpharma Pharmaceuticals Llc Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
US20100152221A1 (en) * 2007-12-17 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US20100266645A1 (en) * 2007-12-17 2010-10-21 Alfred Liang Pharmaceutical compositions
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition

Similar Documents

Publication Publication Date Title
US2981641A (en) Tobacco products
DE1517311A1 (en) Method and means for incorporating flavors into tobacco
WO1987006104A1 (en) Improvements in and relating to tobacco products
EP0052969A3 (en) Flavorant compounds, their pyrolysis products, and smoking and food compositions containing them
DE2356706A1 (en) SMOKE MIXTURES
ATE7260T1 (en) FLAVORING COMPOSITION FOR TOBACCO, PROCESS FOR PRODUCTION THEREOF AND TOBACCO PRODUCT CONTAINING SUCH COMPOSITION.
US3071509A (en) N-alkyl-nornicotine:nicotine antagonist
US3136319A (en) Smoking tobacco product having menthyl keto ester additive
US3890981A (en) Novel process for altering the organoleptic properties of tobacco using one or more alpha-pyrones and process
US3126012A (en) Smqeong tobacco additives in the form
EP0008299A1 (en) Poly(isopropenyl esters) as carboxylic acid-release agents on tobacco.
US3334637A (en) Smoking product having flavorant additive
US4538628A (en) Smoking compositions containing a dioxane diester flavorant-release additive
US4183362A (en) Decreasing the burn rate of smoking tobaccos
US3217716A (en) Tobacco composition
US2872360A (en) Tobacco
US2733174A (en) Compositions containing monosodium
US3280824A (en) Tobacco
JP2763637B2 (en) Oxo-ionol carbonate useful as a tobacco flavor
US2978365A (en) Tobacco
US3381690A (en) Tobacco product
US2392514A (en) Adjunct for tobacco
DE2309152A1 (en) SMOKE MIXTURE
US3529607A (en) Method of influencing the flavor of tobacco
US3547133A (en) Tobacco having an oxadiazole additive